Cavitation Technologies cash flow, quarter by quarter
Latest: Q1 FY27 · from the cash-flow statements filed with the SEC
Free cash flow−$128K in Q1 FY27 · −$664K over twelve months
Operating cash flow−$128K
Free cash flow−$128K
Analysis
In Q1 FY27, Cavitation Technologies generated −$128K of operating cash flow. That is $91K more than in Q1 FY26 (−$219K).
Over the twelve months to Sep 30, 2026, operating cash flow was −$664K; the largest uses were operating cash flow ($664K); besides operations, cash came from shares issued ($388K), other financing ($175K); the cash balance rose by $64K.
Operating cash flow was −$128K against net income of −$208K. The largest differences: employee-related liabilities +$28K, payables −$16K, receivables −$0.
Free cash flow
Operating cash flow less capital spending.Latest (Q1 FY27): Operating cash flow −$128K, Capital spending $0.
Capital allocation, year by year
Over these 5 years operating cash flow totalled −$2.3M; the largest uses were operating cash flow ($2.5M) and net borrowing ($15K). Cash-flow statements as filed.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Every quarter
Quarter
Operating cash flow
Net borrowing (+) / repaid (−)
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q1 FY27
−$128K
$65K
$140K
−$77K
−$128K
Q4 FY26
−$228K
—
$75K
$28K
−$228K
Q3 FY26
−$126K
$50K
—
−$14K
−$126K
Q2 FY26
−$182K
—
$173K
−$1K
−$182K
Q1 FY26
−$219K
—
—
$219K
−$219K
Q4 FY25
−$182K
−$1K
—
$183K
−$182K
Q3 FY25
−$248K
−$1K
—
$249K
−$248K
Q2 FY25
−$201K
—
—
−$679K
−$201K
Cavitation Technologies: income statement and cash flow
Cavitation Technologies, Q3 FY26: revenue $3K (-98% year over year). The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.